Enantiomeric profiling of chiral pharmacologically active compounds in the environment with the usage of chiral liquid chromatography coupled with tandem mass spectrometry

Dolores Camacho-Muñoz, Bruce Petrie, Erika Castrignanò, Barbara Kasprzyk-Hordern*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

22 Citations (Scopus)

Abstract

The issue of drug chirality is attracting increasing attention among the scientific community. The phenomenon of chirality has been overlooked in environmental research (environmental occurrence, fate and toxicity) despite the great impact that chiral pharmacologically active compounds (cPACs) can provoke on ecosystems. The aim of this paper is to introduce the topic of chirality and its implications in environmental contamination. Special attention has been paid to the most recent advances in chiral analysis based on liquid chromatography coupled with mass spectrometry and the most popular protein based chiral stationary phases. Several groups of cPACs of environmental relevance, such as illicit drugs, human and veterinary medicines were discussed. The increase in the number of papers published in the area of chiral environmental analysis indicates that researchers are actively pursuing new opportunities to provide better understanding of environmental impacts resulting from the enantiomerism of cPACs.

Original languageEnglish
Pages (from-to)303-314
Number of pages12
JournalCurrent Analytical Chemistry
Volume12
Issue number4
DOIs
Publication statusPublished - 1 Aug 2016

Keywords

  • Analysis
  • Chiral chromatography
  • Chiral drugs
  • Environment
  • Mass spectrometry
  • Pharmaceuticals
  • Wastewater

Fingerprint

Dive into the research topics of 'Enantiomeric profiling of chiral pharmacologically active compounds in the environment with the usage of chiral liquid chromatography coupled with tandem mass spectrometry'. Together they form a unique fingerprint.

Cite this